Back
Calidi Biotherapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
22
CLDI
Calidi Biotherapeutics, Inc.
Last Price:
$1.28
Seasonality Move:
-32.48%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLDI is experiencing slight buying pressure.
Calidi Biotherapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.34 | Sell |
| 20-day SMA: | 1.42 | Sell |
| 50-day SMA: | 1.48 | Sell |
| 200-day SMA: | 3.98 | Sell |
| 8-day EMA: | 1.35 | Sell |
| 20-day EMA: | 1.4 | Sell |
| 50-day EMA: | 1.59 | Sell |
| 200-day EMA: | 10.12 | Sell |
Calidi Biotherapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 40.18 | Sell |
| Chaikin Money Flow: | 13137 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.34 - 1.5) | Sell |
| Bollinger Bands (100): | (0.68 - 3.32) | Sell |
Calidi Biotherapeutics, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Calidi Biotherapeutics, Inc. Stock
Is Calidi Biotherapeutics, Inc. Stock a Buy?
-
Calidi Biotherapeutics, Inc. share price is 1.29 while CLDI 8-day simple moving average is 1.34, which is a Sell signal.
-
The stock price of CLDI is 1.29 while Calidi Biotherapeutics, Inc. 20-day SMA is 1.42, which makes it a Sell.
-
Calidi Biotherapeutics, Inc. 50-day simple moving average is 1.48 while CLDI share price is 1.29, making it a Sell technically.
-
CLDI stock price is 1.29 and Calidi Biotherapeutics, Inc. 200-day simple moving average is 3.98, creating a Sell signal.
CLDI Technical Analysis vs Fundamental Analysis
Sell
22
Calidi Biotherapeutics, Inc. (CLDI)
is a Sell
Is Calidi Biotherapeutics, Inc. a Buy or a Sell?
-
Calidi Biotherapeutics, Inc. stock is rated a SellThe current Calidi Biotherapeutics, Inc. [CLDI] share price is $1.29. The Score for CLDI is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
Calidi Biotherapeutics, Inc. Stock Info
Market Cap:
9.2M
Price in USD:
1.29
Share Volume:
26.3K
Calidi Biotherapeutics, Inc. 52-Week Range
52-Week High:
19.20
52-Week Low:
1.10
Sell
22
Calidi Biotherapeutics, Inc. (CLDI)
is a Sell
Calidi Biotherapeutics, Inc. Share Price Forecast
-
What is the Calidi Biotherapeutics, Inc. stock price today?The Calidi Biotherapeutics, Inc. stock price is 1.29 USD today.
-
Will CLDI stock go up or go down?Calidi Biotherapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Calidi Biotherapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Calidi Biotherapeutics, Inc. is overvalued.
Is Calidi Biotherapeutics, Inc. Stock a Buy?
-
Calidi Biotherapeutics, Inc. share price is 1.29 while CLDI 8-day exponential moving average is 1.35, which is a Sell signal.
-
The stock price of CLDI is 1.29 while Calidi Biotherapeutics, Inc. 20-day EMA is 1.40, which makes it a Sell.
-
Calidi Biotherapeutics, Inc. 50-day exponential moving average is 1.59 while CLDI share price is 1.29, making it a Sell technically.
-
CLDI stock price is 1.29 and Calidi Biotherapeutics, Inc. 200-day simple moving average is 10.12, creating a Sell signal.
Fundamental Analysis of Calidi Biotherapeutics, Inc.
Is Calidi Biotherapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and an increase next year of $0.13 per share.
Technical Analysis of Calidi Biotherapeutics, Inc.
Should I short Calidi Biotherapeutics, Inc. stock?
-
CLDI Moving Average Covergence Divergence (MACD) indicator is -0.05, suggesting Calidi Biotherapeutics, Inc. is a Sell
-
Calidi Biotherapeutics, Inc. Relative Strength Index (RSI) is 40.18, which suggest Calidi Biotherapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Calidi Biotherapeutics, Inc. is (1.34 - 1.5), which suggest Calidi Biotherapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Calidi Biotherapeutics, Inc. is (0.68 - 3.32), which suggest Calidi Biotherapeutics, Inc. is a Sell
* Calidi Biotherapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.